[PDF] Top 20 FORMULATION AND EVALUATION OF TINIDAZOLE MODIFIED RELEASE DOSAGE FORMS

... The main aim of the work is to investigate the effect of cyclodextrin complex with poorly soluble drug like Tinidazole. In this study we prepared various inclusion complexes by using solvent method. The prepared ... See full document

... Studies done on granules of CF formulation were found suitable and useful for compressing granules in tablet dosage form. Physical parameters and important results of core tablet of CF is presented in Table ... See full document

... After evaluation of powder blend Immediate release tablets and sustained release tablets were prepared by Direct Compression granulation method using (4mm diameter, round flat faced punches) multiple ... See full document

... The formulation of antispasmodic agent in pellet, is to improve its oral bioavailability and possibility to restrict its absorption at colon, pellets were prepared by drug layering technique in three trails (T1 – ... See full document

... India). FORMULATION AND EVALUATION OF EXTENDED RELEASE DOSAGE FORM OF METFORMIN HYDROCHLORIDE USING A COMBINED HYDROPHOBIC AND HYDOPHILIC MATRIX: RATE OF IN-VITRO AND IN-VIVO RELEASE ... See full document

... station dissolution rate test apparatus (Campbell electronics) with a paddle stirrer at 50 rpm and at temperature 37±0.5°C. At regular intervals, the sample (10 ml) was withdrawn and replaced with same volume of fresh ... See full document

... semisolid dosage form appropriate for topical dermatological ...drug release than the hydrophobic ...cream formulation, the cream was reformulated so as to contain lower drug strength ...cream ... See full document

... pharmaceutical dosage forms like semisolidsTopical preparations are used for the localized effects at the site of their application by virtue of drug penetration into the underlying layers of skin or mucous ... See full document

... sustained release matrix tablet of Donepezil hydrochloride stable and provide sustained therapeutically effective plasma level over a 24 hour period with reduced undesired side effects, and developed dosage ... See full document

... controlled release medications. Some of these are: continuous release (CR), depot release (DR), slow release (SR), long acting (LA), long lasting (LL), long term release (LTR), ... See full document

...  From the data obtained, it’s observed that the formulation containing crosscarmellose sodium 4mg in formulation F2 with 100mg of tablet eight show the percentage[r] ... See full document

... used dosage form because of its convenience in terms of self- administration, compactness, and ease in ...disintegrating dosage forms has generally been pediatric, geriatric, and bedridden or ... See full document

... work, modified release gliclazide once a daily tablet were designed for non-insulin dependent diabetes for better patient compliance by direct compression method, HPMC was used as polymer, Dibasic calcium ... See full document

... proper dosage regimens is an important element in accomplishing the goal 1 to achieve a steady-state blood or tissue level that is therapeutically effective and non-toxic for an extended period of ...sustained ... See full document

... on formulation, characterization and the prime mechanism of floatation to achieve gastric retention, including kinetic consideration for ...different dosage forms are formulated and it was observed ... See full document

... at formulation and evaluation of the mucoadhesive microspheres forsalbutamol sulphate using thiolated pectin as a polymer for controlled release dosage form by optimization technique using ... See full document

... oral dosage forms by improving the bioavailability 1 and by reducing the side effects, but the number of emulsion formulations currently in use are few compared with other oral dosage forms ... See full document

... once-daily modified release (MR) matrix tablet formulations of Capecitabine (CPC), an anti-cancer drug, using Hydroxy Propyl Methyl Cellulose (HPMC K4M & HPMC K15M) as drug release ...as ... See full document

... to release the drug without any delay after ...not release the drug for prolonged periods of time and also the management of a chronic disease with conventional formulation are very ...problem, ... See full document

... and formulation developed to efficiently transport a pharmacologically active compound in the body to achieve therapeutic efficiency in a safe ...the release profile which in turn modulates the ... See full document